GXYLT2 Identified as a Key Prognostic Biomarker and Molecular Driver of Aggressiveness in Gastric Cancer
A groundbreaking study recently published in the prestigious journal Genes & Diseases has unveiled the critical role of glucoside xylosyltransferase 2 (GXYLT2) as both a...
















